KR930703613A - 시료 희석물중 과산화물 디스뮤타제의 용도 - Google Patents

시료 희석물중 과산화물 디스뮤타제의 용도

Info

Publication number
KR930703613A
KR930703613A KR1019930702190A KR930702190A KR930703613A KR 930703613 A KR930703613 A KR 930703613A KR 1019930702190 A KR1019930702190 A KR 1019930702190A KR 930702190 A KR930702190 A KR 930702190A KR 930703613 A KR930703613 A KR 930703613A
Authority
KR
South Korea
Prior art keywords
peroxide dismutase
sample
diluent
dismutase
peroxide
Prior art date
Application number
KR1019930702190A
Other languages
English (en)
Inventor
엘. 길버트 아드리엔
엘. 스튜어트 제임스
엘. 키드 사라
제이. 도슨 조오지
더블유. 파일 스티븐
Original Assignee
챨스 엠. 브록
애보트 래보러토리즈
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24596744&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR930703613(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 챨스 엠. 브록, 애보트 래보러토리즈 filed Critical 챨스 엠. 브록
Publication of KR930703613A publication Critical patent/KR930703613A/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

본 발명은 항체를 검출하는 개선된 방법에 관한 것이다. 이 방법은 (a) 시료를 과산화물 디스뮤타제를 포함하는 희석물과 혼합하고, (b) 희석된 시료를 과산화물 디스큐타제와의 융합 단백질로서 발현된 제조합체 항원 하나 이상과 접촉시키는 단계를 수반한다.

Description

시료 희석물중 과산화물 디스뮤타제의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1도는 HCV 그릇된 양성 시료군에 SOD를 첨가한 효과를 나타낸다.

Claims (8)

  1. (a)시료를 과산화물 디스뮤타제를 포함하는 희석물과 혼합하고, (b)희석된 시료를 과산화물 디스뮤타제와의 융합 단백질로서 발현된 제조합체 항원 하나 이상과 접촉시키는 단계를 포함함을 특징으로 하며, 시료중의 항체를 검출하는 방법.
  2. 제1항에 있어서, 과산화물 디스뮤타제가 제조합체 단백질인 방법.
  3. 제1항에 있어서, 과산화물 디스뮤타제의 농도가 희석물 1ℓ당 약 0.001g내지 약 1.0g인 방법.
  4. 제1항에 있어서, 과산화물 디스뮤타제의 농도가 희석물 1ℓ당 약 0.01g내지 약 0.1g인 방법.
  5. 제1항에 있어서, 항-HCV 항체를 검출하는 방법.
  6. 제1항에 있어서, 제조합체 항원이 SOD-c100-3인 방법.
  7. (a)시료를 과산화물 디스뮤타제를 포함하는 희석물과 혼합하고, (b)희석된 시료를 과산화물 디스뮤타제와의 융합 단백질로서 발현된 재조합체 항원 하나 이상과 접촉시키는 단계를 포함함을 특징으로하여, 시료중의 항-HCV 항체를 검출하는 방법.
  8. 제7항에 있어서, 재조합체 항원이 SOD-c100-3인 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930702190A 1991-01-25 1992-01-04 시료 희석물중 과산화물 디스뮤타제의 용도 KR930703613A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US64737491A 1991-01-25 1991-01-25
US07/647,374 1991-01-25
PCT/US1992/000604 WO1992013275A1 (en) 1991-01-25 1992-01-24 Use of superoxide dismutase in specimen diluent

Publications (1)

Publication Number Publication Date
KR930703613A true KR930703613A (ko) 1993-11-30

Family

ID=24596744

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930702190A KR930703613A (ko) 1991-01-25 1992-01-04 시료 희석물중 과산화물 디스뮤타제의 용도

Country Status (8)

Country Link
US (1) US5330893A (ko)
EP (1) EP0568639A4 (ko)
JP (1) JPH06506770A (ko)
KR (1) KR930703613A (ko)
AU (1) AU658395B2 (ko)
CA (1) CA2101056A1 (ko)
TW (1) TW213981B (ko)
WO (1) WO1992013275A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2803020B2 (ja) * 1994-05-06 1998-09-24 ダイナボット株式会社 Ｈｉｖ関連抗体測定法
JP2803019B2 (ja) * 1994-05-06 1998-09-24 ダイナボット株式会社 Ｈｃｖ関連抗体測定法
AU6946394A (en) * 1994-05-09 1995-11-29 Abbott Laboratories Method and reagents useful for improving immunoassay specificity
US6511812B1 (en) * 1994-05-09 2003-01-28 Abbott Laboratories Method and test kit for use in improving immunoassay specificity
BR9906660A (pt) 1998-07-30 2000-08-29 Advanced Life Science Inst Inc Processo para medir vìrus da hepatite c
CA2824758C (en) 2011-01-13 2019-06-04 Ortho-Clinical Diagnostics, Inc. Treponema pallidum triplet antigen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4940659A (en) * 1987-02-20 1990-07-10 Monoclonetics International, Inc. Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome
EP0318216B2 (en) * 1987-11-18 2001-08-29 Chiron Corporation NANBV diagnostics
US5147783A (en) * 1988-05-27 1992-09-15 Ube Industries, Ltd. Methods to screen for ovarian cancer and myocardial infarction

Also Published As

Publication number Publication date
AU1335492A (en) 1992-08-27
EP0568639A1 (en) 1993-11-10
TW213981B (ko) 1993-10-01
JPH06506770A (ja) 1994-07-28
CA2101056A1 (en) 1992-07-26
WO1992013275A1 (en) 1992-08-06
EP0568639A4 (en) 1994-06-29
US5330893A (en) 1994-07-19
AU658395B2 (en) 1995-04-13

Similar Documents

Publication Publication Date Title
ES2080099T3 (es) Ensayo para la hepatitis c.
ATE348337T1 (de) Hcv-antigen/antikörper-kombinations-assay
PT649537E (pt) Imunoanalises para anticorpos anti-vhc utilizando antigenios com epitopos conformacionais
ATE438097T1 (de) Gut reproduzierbares agglutinations- immunoassayverfahren und reagenzien
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
ES2076948T3 (es) Inmunoensayo sobre una superficie solida prebloqueada.
GB8915512D0 (en) Silver enhanced gold-labelled immuno assay method
FI935217A0 (fi) Basisk dissocieringsanalys
ES2145746T3 (es) Analisis de deteccion de hepatitis c.
KR930703613A (ko) 시료 희석물중 과산화물 디스뮤타제의 용도
ATE199783T1 (de) Immunoassay zur aviditätsbestimmung von immunglobulinen
KR930008155A (ko) 씨형 간염 바이러스(hcv)에 대한 모노클로날 항체
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
KR890014729A (ko) 비-a, 비-b형 간염 감염된 간에 대한 모노클로날 항체의 제조방법
ATE112392T1 (de) Agglutinationskomplex zum nachweis von blutgruppen.
KR930008463A (ko) 치주 질환과 연관된 미생물들을 검증하기 위한 세정 조성물, 시험키트 및 방법
KR930004328A (ko) 비-a, 비-b형 펩티드
ATE143699T1 (de) Monoklonale antikörper gegen sulfonierte polymere
KR930007970A (ko) 비-에이 형 , 비-비형 펩티드
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
CA2116026A1 (en) Hepatitis c assay utilizing recombinant antigens to c-100 region
KR910001378A (ko) HIV p24 정량 패널
KR900018368A (ko) 하나 또는 그 이상의 관련 비루스의 항원에 대해 지시된 항체 검출용 진단 시험물
KR940000871A (ko) 한국형 c형 간염의 진단 방법 및 진단키트
RU95114865A (ru) Способ агглютинационного иммунологического анализа при помощи дисперсного препарата на основе оксида железа (iii)

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid